XASX
CSX
Market cap28mUSD
Oct 09, Last price
0.42AUD
1D
-16.00%
1Q
5.00%
IPO
-94.17%
Name
Cleanspace Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CleanSpace Holdings Limited is a global enterprise focused on the design, manufacturing, and sale of personal respiratory protective equipment and related services. The company's advanced solutions serve healthcare professionals and a wide array of industrial employers worldwide. Their key offerings include CleanSpace HALO, specifically designed for medical and healthcare environments; CleanSpace ULTRA, providing robust face, eye, and water-resistant protection; CleanSpace2, a versatile respirator for general industrial settings; and CleanSpace EX, engineered for safe operation in potentially explosive atmospheres. Furthermore, CleanSpace supplies an extensive range of accessories and consumable products, such as various masks, replacement filters, charging and storage solutions, specialized biohoods, adaptors, identification elements, headgear components, protective visors, and essential spare parts. This protective gear is deployed across diverse and demanding sectors, including mining, welding, construction, laboratories, dental practices, wastewater management, and critical healthcare and first responder roles. Founded in 2009, CleanSpace Holdings Limited maintains its headquarters in St Leonards, Australia.
Key people
Graham Mclean
Non-Executive Chairman of the Board · since 2024
Gabrielle O'carroll
Chief Executive Officer · since 2025
Bree Greeff
Chief Financial Officer · since 2024
Dan Kao
Executive Director, Director of Operations
Elissa Hansen
Joint Company Secretary · since 2020
Paul Cassano
Non-Executive Director · since 2023
Non-Executive Independent Director · since 2021
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||